The value of hepatic diffusion-weighted MR imaging in demonstrating hepatic congestion secondary to pulmonary hypertension

Cardiovascular Ultrasound

Volumn 8, Issue 1, 2010, Pages

  Dogan, Yuksel ^a   Soylu, Aliye ^a   Kilickesmez, Ozgur ^b   Demirtas, Tuna ^a   Kilickesmez, Kadriye Orta ^c   Dogan, Sebahat Nacar ^d   Eren, Gulay ^a   Sevindir, Isa ^a   Yasar, Nurgul ^a   Poturoglu, Sule ^e   Sonmez, Kenan ^f  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^f KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; LACTATE DEHYDROGENASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CHEMISTRY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT ATRIUM; HEPATIC VEIN; HUMAN; INFERIOR CAVA VEIN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CONGESTION; LIVER SIZE; MAJOR CLINICAL STUDY; MALE; PULMONARY ARTERY; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; HEPATOMEGALY; LIVER; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HEPATOMEGALY; HUMANS; HYPERTENSION, PULMONARY; LIVER; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 77954686812     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-8-28     Document Type: Article

References (46)

1. Diagnostics in pulmonary hypertension. CM Schannwell S Steiner BE Strauer, J Physiol Pharmacol 2007 58 59 602
2. Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy. JM Arcidi GW Mooreand JR GM Hutchins, AM J Pathol 1981 104 159 166 6455066
3. Pulmonary arterial hypertension. X Jais O Sitbon L Savale D Montani, Rev Prat 2008 58 1997 2110 19143271
4. Hepatic venous outflow obstruction: three similar syndromes. UD Bayraktar S Seren Y Bayraktar, World J Gastroenterol 2007 13 1912 1927 17461490
5. ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography. A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, J Am Coll Cardiol 2007 50 187 204 10.1016/j.jacc.2007.05.003 17616306
6. Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity? D Mutlak D Aronson J Lessick SA Reisner S Dabbah Y Agmon, Chest 2009 135 115 21 10.1378/chest.08-0277 18719061
7. Chronic congestive heart failure: observations at abdominal ultrasound with a comparison of abdominal veins in healthy individuals. JV Kaude P Jakobson, Angiology 1982 33 199 205 10.1177/000331978203300307 7065465
8. Right heart failure: diagnosis via ultrasonography of the inferior vena cava and hepatic veins. R Goei HR Ronnen AH Kessels JA Kragten, Rofo 1997 166 36 9 9072102
9. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJ Tolia M Losada JS Babb ES Chan MA Bannan H Tobias, AJR Am J Roentgenol 2007 189 799 806 10.2214/AJR.07.2086 17885048
10. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. M Lewin A Poujol-Robert PY Bolle D Wendum E Lasnier M Viallon J Guéchot C Hoeffel L Arrivé JM Tubiana R Poupon, Hepatology 2007 46 658 65 10.1002/hep.21747 17663420
11. ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology(ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Authors/Task Force Members N Galie MM Hoeper M Humbert A Torbicki JL Vachiery JA Barbera M Beghetti P Corris S Gaine JS Gibbs MA Gomez-Sanchez G Jondeau W Klepetko C Opitz A Peacock L Rubin M Zellweger G Simonneau, Eur Heart J 2009 30 2493 537 10.1093/eurheartj/ehp297 19713419
12. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. GT Lau HC Tan L Kritharides, Am J Cardiol 2002 90 1405 1409 10.1016/S0002-9149(02)02886-2 12480058
13. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. RM Lang M Bierig RB Devereux FA Flachskampf E Foster PA Pellikka MH Picard MJ Roman J Seward JS Shanewise SD Solomon KT Spencer MS Sutton WJ Stewart Chamber Quantification Writing Group American Society of Echocardiography's Guidelines and Standards Committee European Association of Echocardiography, J Am Soc Echocardiogr 2005 18 1440 1463 10.1016/j.echo.2005.10.005 16376782
14. Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates. CL Cotton S Gandhi PT Vaitkus MG Massad E Benedetti RG Mrtek, Liver Transpl 2002 8 1051 1054 10.1053/jlts.2002.35554 12424719
15. Right heart failure: diagnosis via ultrasonography of the inferior vena cava and hepatic veins. R Goei HR Ronnen AH Kessels JA Kragten, Rofo 1997 166 36 9 9072102
16. Passive Hepatic Congestion in Heart Failure: CT Abnormalities. JS Moulton BL Miller GD Dodd DN Vu, AJR 1998 151 939 942
17. Portal ven pulsatility ratio and heart failure. D Catalano G Caruso S DiFazzio G Carpinteri N Scalisi GM Trovato, J Clin Ultrasound 1998 26 27 31 10.1002/(SICI)1097-0096(199801)26:1<27::AID-JCU6>3.0.CO;2-L 9475205
18. Gray and color Doppler ultrasonography in differentiation between chronic viral hepatitis and compensated early stage cirrhosis. P Iliopoulos M Vlychou V Margaritis I Tsamis K Tepetes T Petsas C Karatza, J Gastrointestin Liver Dis 2007 16 279 286 17925922
19. Ischemic hepatitis: Clinical presentation and pathogenesis. RK Seeto B Fenn DC Rockey, Am J Med 2000 109 109 113 10.1016/S0002-9343(00)00461-7 10967151
20. The heart and the liver. S Moller CW Dümcke A Krag, Expert Rev Gastroenterol Hepatol 2009 3 51 64 10.1586/17474124.3.1.51 19210113
21. Hypoxic Hepatopathy: Pathophysiology and Prognosis. R Birrer Y Takuda T Takara, Internal Medicine 2007 46 1063 1070 10.2169/internalmedicine.46.0059 17634701
22. Impact of tricuspid regurgitation on long-term survival. J Nath E Foster PA Heidenreich, J Am Coll Cardiol 2004 43 405 409 10.1016/j.jacc.2003.09.036 15013122
23. Two simple echo-Doppler measurements can accurately identify pulmonary hypertension in the large majority of patients with chronic heart failure. L Lanzarini A Fontana C Campana C Klersy, J Heart Lung Transplant 2005 24 745 754 10.1016/j.healun.2004.03.026 15949736
24. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. CS Lam VL Roger RJ Rodeheffer BA Borlaug FT Enders MM Redfield, J Am Coll Cardiol 2009 53 1119 1126 10.1016/j.jacc.2008.11.051 19324256
25. Doppler myocardial imaging for early detection of right ventricular dysfunction in patients with pulmonary hypertension. M Kittipovanonth D Bellavia K Chandrasekaran HR Villarraga TP Abraham PA Pellikka, J Am Soc Echocardiogr 2008 21 1035 1041 10.1016/j.echo.2008.07.002 18765178
26. Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. R Girometti A Furlan M Bazzocchi F Soldano M Isola P Toniutto D Bitetto C Zuiani, Radiol Med 2007 112 394 408 10.1007/s11547-007- 0149-1 17440695
27. Diffusion-weighted MRI in the body: applications and challenges in oncology. DM Koh DJ Collins, AJR Am J Roentgenol 2007 188 1622 1635 10.2214/AJR.06.1403 17515386
28. Non-breath-hold high b-value diffusion-weighted MRI with parallel imaging technique: apparent diffusion coefficient determination in normal abdominal organs. O Kilickesmez G Yirik S Bayramoglu T Cimilli S Aydin, Diagn Interv Radiol 2008 14 83 87 18553281
29. Passive hepatic congestion: cross-sectional imaging features. RM Gore DG Mathieu EM White GG Ghahremani JS Panella D Rochester, AJR Am J Roentgenol 1994 162 71 75 8273693
30. Diffusion MR imaging: clinical applications. D Le Bihan R Turner P Douek N Patronas, AJR Am J Roentgenol 1992 159 591 599 1503032
31. Molecular diffusion, tissue microdynamics and microstructure. D Le Bihan, NMR Biomed 1995 8 375 386 10.1002/nbm.1940080711 8739274
32. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. T Kim T Murakami S Takahashi M Hori K Tsuda H Nakamura, AJR Am J Roentgenol 1999 173 393 398 10430143
33. Abdominal and pelvic applications of opposed-phase MR imaging. JP Earls GA Krinsky, AJR Am J Roentgenol 1997 169 1071 1077 9308467
34. Evaluation of early stage diffused liver lesions with MR functional diffusion-weighted imaging - an experimental study. S Guan WD Zhao KR Zhou WJ Peng F Tang J Mao G Cao F Sun, Zhonghua Gan Zang Bing Za Zhi 2005 13 524 527 16042891
35. The value of diffusion-weighted imaging in characterizing focal liver masses. K Sandrasegaran FM Akisik C Lin B Tahir J Rajan AM Aisen, Acad Radiol 2009 16 1208 1214 10.1016/j.acra.2009.05.013 19608435
36. Diffusion-weighted magnetic resonance imaging of the liver in hepatitis B patients with Child-Pugh a cirrhosis. FO Hsu YY Chiou CY Chen GC Liu HC Chu HC Liu HM Chu JS Hsu, Kaohsiung J Med Sci 2007 23 442 446 10.1016/S1607-551X(08) 70051-2 17766212
37. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. M Koinuma I Ohashi K Hanafusa H Shibuya, J Magn Reson Imaging 2005 22 80 85 10.1002/jmri.20344 15971188
38. Value of apparent diffusion coefficient measurement for discrimination of focal benign and malignant hepatic masses. O Kilickesmez S Bayramoglu E Inci T Cimilli, J Med Imaging Radiat Oncol 2009 53 50 55 10.1111/j.1754-9485.2009. 02036.x 19453528
39. Respiratory-triggered versus breath-hold diffusion-weighted MRI of liver lesions: comparison of image quality and apparent diffusion coefficient values. H Kandpal R Sharma KS Madhusudhan KS Kapoor, AJR Am J Roentgenol 2009 192 915 922 10.2214/AJR.08.1260 19304695
40. Diffusion-weighted magnetic resonance imaging of the liver in hepatitis B patients with Child-Pugh a cirrhosis. FO Hsu YY Chiou CY Chen GC Liu HC Chu HC Liu HM Chu JS Hsu, Kaohsiung J Med Sci 2007 23 442 446 10.1016/S1607-551X(08) 70051-2 17766212
41. Diffusion-weighted MR imaging of the liver of hepatitis C patients. Y Boulanger M Amara L Lepanto G Beaudoin BN Nguyen G Allaire M Poliquin V Nicolet, NMR Biomed 2003 16 132 136 10.1002/nbm.818 12884356
42. Measurement of the apparent diffusion coefficient in the liver: is it a reliable index for hepatic disease diagnosis? K Nasu Y Kuroki R Sekiguchi T Kazama H Nakajima, Radiat Med 2006 24 438 444 10.1007/s11604-006-0053-y 16958425
43. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. B Taouli AJ Tolia M Losada JS Babb ES Chan MA Bannan H Tobias, AJR Am J Roentgenol 2007 189 799 806 10.2214/AJR.07.2086 17885048
44. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. N Galiè Lj Rubin M Hoeper P Jansa H Al-Hiti G Meyer E Chiossi A Kusic-Pajic G Simonneau, Lancet 2008 371 2093 2100 10.1016/S0140-6736(08)60919-8 18572079
45. Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension. LE McLure AJ Peacock, Eur Respir J 2009 33 1454 1466 10.1183/09031936.00139907 19483048
46. The role of 1.5T cardiac MRI in the diagnosis, prognosis and management of pulmonary arterial hypertension. G Marrone G Mamone A Luca P Vitulo A Bertani M Pilato B Gridelli, Int J Cardiovasc Imaging 2010 26 665 685 10.1007/s10554-010-9623-2 20336377